The gut microbiota and disease - an inner repository for drug discovery

Drug Discovery Today: Therapeutic Strategies

Volumn 4, Issue 3, 2007, Pages 195-200

  Shanahan, Fergus ^a   Kiely, Barry ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BACTERIAL DNA; BACTERIAL POLYSACCHARIDE; BACTERIOCIN; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CONJUGATED LINOLEIC ACID; CPG OLIGODEOXYNUCLEOTIDE; DEFENSIN; IMMUNOMODULATING AGENT; INSULIN; INTERLEUKIN 10; INTESTINAL TREFOIL FACTOR; MORPHINE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; OLIGONUCLEOTIDE; PROBIOTIC AGENT; THYMIDYLATE SYNTHASE; TOLL LIKE RECEPTOR 9;

ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BACTERIAL INFECTION; CELL PROTECTION; CELLULAR IMMUNITY; CROHN DISEASE; DRUG RESEARCH; ENTERITIS; ENTEROBACTERIACEAE; ENTEROPATHY; FUNCTIONAL FOOD; GENE DELIVERY SYSTEM; HUMAN; IMMUNOMODULATION; INFLAMMATORY DISEASE; INTESTINE FLORA; IRRITABLE COLON; LISTERIOSIS; LIVER; MALIGNANT NEOPLASTIC DISEASE; METABOLIC CAPACITY; MICROBIAL BIOMASS; MICROBIAL DIVERSITY; NONHUMAN; OBESITY; REVIEW; SIGNAL TRANSDUCTION;

EID: 46149125505     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2008.02.006     Document Type: Review

References (40)

1. Jia W., et al. Gut microbiota: a potential new territory for drug targeting. Nat. Rev. Drug Discov. 7 (2008) 123-129
2. O'Hara A.M., and Shanahan F. Gut microbiota: mining for therapeutic potential. Clin. Gastroenterol. Hepatol. 5 (2007) 274-284
3. Hugot J.P., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
4. Ogura Y., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
5. Strober W., et al. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 117 (2007) 514-521
6. Baumgart D.C., and Carding S.R. Inflammatory bowel disease: cause and immunobiology. Lancet 369 (2007) 1627-1640
7. Marchesi J., and Shanahan F. The normal intestinal microbiota. Curr. Opin. Infect. Dis. 20 (2007) 508-513
8. Ley R.E., et al. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 (2006) 837-848
9. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 449 (2007) 819-826
10. O'Hara A.M., and Shanahan F. The gut as a forgotten organ. EMBO Rep. 7 (2006) 688-693
11. Turnbaugh P.J., et al. The human microbiome project. Nature 449 (2007) 804-810
12. Bik E.M., et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 732-737
13. Kassinen A., et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133 (2007) 24-33
14. Shanahan F. Irritable bowel syndrome: shifting the focus toward the gut microbiota. Gastroenterology 133 (2007) 340-342
15. Frank D.N., et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 13780-13785
16. Hooper L.V., et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291 (2001) 881-884
17. Sudo N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiol. 558 Pt 1 (2004) 263-275
18. Xu J., and Gordon J.I. Inaugural article: honor thy symbionts. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10452-10459
19. Macpherson A.J., and Smith K. Mesenteric lymph nodes at the center of immune anatomy. J. Exp. Med. 203 (2006) 497-500
20. Rakoff-Nahoum S., et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229-241
21. Kumar A., et al. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J. 26 (2007) 4457-4466
22. Cotter P.D., et al. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3 (2005) 777-788
23. Corr S.C., et al. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 7617-7621
24. Rea M.C., et al. Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains. J. Med. Microbiol. 56 Pt 7 (2007) 940-946
25. Mazmanian S.K., et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122 (2005) 107-118
26. Mazmanian S.K., and Kasper D.L. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat. Rev. Immunol. 8 (2006) 777-788
27. Shanahan F. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease. Am. J. Physiol. Gastrointest. Liver Physiol. 288 (2005) G417-G421
28. Obermeier F., et al. Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin. Exp. Immunol. 134 (2003) 217-224
29. Yan F., et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132 (2007) 562-575
30. Fujiya M., et al. The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe 1 (2007) 299-308
31. Grangette C., et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10321-10326
32. Coakley M., et al. Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species. J. Appl. Microbiol. 94 (2003) 138-145
33. Rosberg-Cody E., et al. Mining the microbiota of the neonatal gastrointestinal tract for conjugated linoleic acid-producing bifidobacteria. Appl. Environ. Microbiol. 70 (2004) 4635-4641
34. Bäckhed F., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15718-15723
35. Dumas M.E., et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad.Sci. U. S. A. 103 (2006) 12511-12516
36. Rousseaux C., et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 13 (2007) 35-37
37. Shanahan F. Making microbes work for mankind-clever trick or a glimpse of the future for IBD treatment?. Gastroenterology 127 (2004) 667-668
38. Braat H., et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 4 (2006) 754-759
39. Sandler R.S., et al. The burden of selected digestive diseases in the United States. Gastroenterology 122 (2002) 1500-1511
40. Hellier M.D., and Williams J.G. The burden of gastrointestinal disease: implications for the provision of care in the UK. Gut 56 (2007) 165-166